Addition of Metanx in pregabalin partial responders for painful diabetic neuropathy

Objective: To study the effect of addition of Metanx on burning parasthesias in patients with symptomatic diabetic neuropathy who had obtained only partial symptom resolution with pregabalin. Research design and methods: This was an open-label pilot study. There were 16 patients (7 males, 9 females) in the study group and 8 patients (3 males, 5 females) in the control group. A patient numeric rating scale (0 - 10) of neuropathy associated pain was obtained at baseline and at 20 weeks. The control group continued on a fixed dosage of pregabalin (Lyrica) without additional medication, while the study group was supplemented with Metanx (L-methylfolate, methylcobalamin, and pyridoxal 5- phosphate), in addition to being continued on a fixed dosage of pregabalin. Results: After 20 weeks, patients in the study group experienced greater pain relief compared to the control group, (87.5% vs. 25% respectively, p = 0.005). The average pain score reduction after 20 weeks in the study group was 3 compared to0.25 inthe control group (p  may be used for the relief of pain in patients that have obtained only partial resolution of symptomatology from pregabalin.

[1]  R. Schrier,et al.  Total homocysteine is associated with nephropathy in non-insulin-dependent diabetes mellitus. , 1999, Metabolism: clinical and experimental.

[2]  D. Cheng,et al.  Improvement of cutaneous sensitivity in diabetic peripheral neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5'-phosphate. , 2010, Reviews in neurological diseases.

[3]  B. Yaqub,et al.  Effects of methylcobalamin on diabetic neuropathy , 1992, Clinical Neurology and Neurosurgery.

[4]  D. Veber,et al.  New Basis of the Neurotrophic Action of Vitamin B12 , 2003, Clinical chemistry and laboratory medicine.

[5]  S. King.  Diabetic Peripheral Neuropathic Pain , 2006 .

[6]  M. Detke,et al.  Duloxetine vs. placebo in patients with painful diabetic neuropathy , 2005, Pain.

[7]  M. Pfeifer,et al.  Diabetic Peripheral Neuropathy , 1987 .

[8]  J. Duby,et al.  Diabetic neuropathy: an intensive review. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[9]  R. Obeid,et al.  The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases , 2007, Clinical chemistry and laboratory medicine.

[10]  Dan Ziegler,et al.  Diabetic neuropathies: a statement by the American Diabetes Association. , 2005, Diabetes care.

[11]  K. Pietrzik,et al.  Zur Bedeutung ausgewählter Vitamine (B-Vitamine, Vitamin C, Vitamin E) bei Patienten mit Typ-2-Diabetes , 2005 .

[12]  G. Bennett,et al.  Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain. , 2006, Mayo Clinic proceedings.

[13]  P. Ueland,et al.  Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. , 1997, Kidney international.

[14]  A. Beydoun,et al.  Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus: a Randomized Controlled Trial , 1999 .

[15]  D. D. de Luis,et al.  Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2. , 2004, Journal of diabetes and its complications.

[16]  S. Yusuf,et al.  Homocysteine lowering with folic acid and B vitamins in vascular disease. , 2006, The New England journal of medicine.

[17]  H. J. McQuay,et al.  A systematic review of antidepressants in neuropathic pain , 1996, Pain.

[18]  U. Munzel,et al.  Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy , 2006, Diabetes Care.

[19]  A. Mangoni,et al.  Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes. , 2005, American journal of hypertension.

[20]  J. Dora,et al.  Standards of Medical Care in Diabetes—2008 , 2008, Diabetes Care.

[21]  T. Jensen,et al.  Venlafaxine versus imipramine in painful polyneuropathy , 2003, Neurology.

[22]  J. Rosenstock,et al.  Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial , 2004, Pain.

[23]  K. Head.  Peripheral neuropathy: pathogenic mechanisms and alternative therapies. , 2006, Alternative medicine review : a journal of clinical therapeutic.

[24]  B. Venn,et al.  Comparison of the effect of low-dose supplementation with L-5-methyltetrahydrofolate or folic acid on plasma homocysteine: a randomized placebo-controlled study. , 2003, The American journal of clinical nutrition.

[25]  R. Poole,et al.  Pregabalin relieves symptoms of painful diabetic neuropathy , 2004, Neurology.

[26]  G. Bennett,et al.  Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain. , 2006, Mayo Clinic proceedings.

[27]  Thodoris D. Karapantsios,et al.  Standards of Medical Care in Diabetes—2008 The recommendations in this article are based on the evidence reviewed in the following publication: Standards of care for diabetes (Technical Review). Diabetes Care 17:1514–1522, 1994. Originally approved 1988. Most recent review/revision, October 2007. , 2008, Diabetes Care.

[28]  M. Serpell.  Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial , 2002, Pain.

[29]  Tetsuya Watanabe,et al.  Ultra-high dose methylcobalamin promotes nerve regeneration in experimental acrylamide neuropathy , 1994, Journal of the Neurological Sciences.

[30]  A. Boulton,et al.  The global burden of diabetic foot disease , 2005, The Lancet.

[31]  R. Portenoy,et al.  Controlled-release oxycodone for pain in diabetic neuropathy , 2003, Neurology.

[32]  A. Akaike,et al.  Protective effects of methylcobalamin, a vitamin B12 analog, against glutamate-induced neurotoxicity in retinal cell culture. , 1997, Investigative ophthalmology & visual science.

[33]  H. Lehnert,et al.  Relation between homocysteinaemia and diabetic neuropathy in patients with Type 2 diabetes mellitus , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[34]  L. Lamoreaux,et al.  Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. , 2005, The journal of pain : official journal of the American Pain Society.

[35]  Grethe Andersen,et al.  Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial , 1999, PAIN.

[36]  D. Fishbain,et al.  Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. , 2006, Mayo Clinic proceedings.

[37]  D. Wile,et al.  Association of Metformin, Elevated Homocysteine, and Methylmalonic Acid Levels and Clinically Worsened Diabetic Peripheral Neuropathy , 2009, Diabetes Care.